Molecular diversity and evolutionary dynamics of Nipah virus: implications for surveillance and control

Authors

  • Amos Dangana National Reference Laboratory, Nigeria Centre for Disease Control and Prevention Gaduwa, Abuja, Nigeria
  • Adesuyi. A. Omoare National Reference Laboratory, Nigeria Centre for Disease Control and Prevention Gaduwa, Abuja, Nigeria
  • Nanpon Miri National Reference Laboratory, Nigeria Centre for Disease Control and Prevention Gaduwa, Abuja, Nigeria
  • Bwede Eugene Bwede National Reference Laboratory, Nigeria Centre for Disease Control and Prevention Gaduwa, Abuja, Nigeria
  • Mangpin Leviticus Dansura National Reference Laboratory, Nigeria Centre for Disease Control and Prevention Gaduwa, Abuja, Nigeria
  • Villeng Felix Gagari National Reference Laboratory, Nigeria Centre for Disease Control and Prevention Gaduwa, Abuja, Nigeria
  • Nkiruka Lynda Uzoebo National Reference Laboratory, Nigeria Centre for Disease Control and Prevention Gaduwa, Abuja, Nigeria
  • James Avong National Reference Laboratory, Nigeria Centre for Disease Control and Prevention Gaduwa, Abuja, Nigeria
  • John Okoh Nigeria Centre for Disease Control and Prevention, Jabi, Abuja, Nigeria
  • Olakitan Jinadu Nigeria Centre for Disease Control and Prevention, Jabi, Abuja, Nigeria
  • Onakomaiye Demola Nigeria Centre for Disease Control and Prevention, Jabi, Abuja, Nigeria
  • Olajumoke Babatunde National Reference Laboratory, Nigeria Centre for Disease Control and Prevention Gaduwa, Abuja, Nigeria
  • Olajide Idris Nigeria Centre for Disease Control and Prevention, Jabi, Abuja, Nigeria

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20260719

Keywords:

Nipah virus, Phylogenetics, Molecular diversity, Zoonosis, Genomic surveillance, One health, Outbreak control

Abstract

The Nipah virus (NiV) is a highly dangerous zoonotic virus that continues to threaten global health. Its alarming case fatality rate, ability to spread from person to person, and potential to jump from wildlife to humans make it a serious concern. To effectively monitor and control this virus, it’s crucial to understand its molecular diversity and how it evolves. We carried out an extensive review of existing genomic, phylogenetic, and epidemiological research on NiV. Our focus was on understanding its genetic diversity, patterns of recombination, and traits specific to different lineages. We also looked into the current shortcomings in surveillance, diagnostics, and public health responses through a One Health lens. We identified two main lineages—NiV-Malaysia (NiV-MY) and NiV-Bangladesh (NiV-BD)—which show unique transmission patterns and genetic characteristics. Our phylogenomic analysis uncovered lineage-specific mutations in the glycoprotein and polymerase genes, some of which are under positive selection. Additionally, recombination events and mutations within hosts indicate that the virus is adapting. However, there’s still a lack of data from wildlife reservoirs, and many diagnostic tools do not account for genetic variations. These insights underscore the urgent need for improved surveillance strategies, outbreak readiness, and vaccine development. To prevent the emergence of NiV, we urgently need to enhance genomic surveillance, integrate one health approaches across sectors, and conduct functional studies on mutations that define different lineages. Adapting diagnostics and vaccine strategies to keep pace with viral evolution will be crucial in reducing the risk of future outbreaks.

Metrics

Metrics Loading ...

References

AbuBakar S, Chang LY, Ali AR, Sharifah SH, Yusoff K, Zamrod Z. Isolation and molecular identification of Nipah virus from pigs. Emerg Infect Dis. 2004;10(12):2228-30. DOI: https://doi.org/10.3201/eid1012.040452

Aguilar HC, Ataman ZA, Aspericueta V, Fang AQ, Stroud M, Negrete OA, et al. A novel receptor-induced activation site in the Nipah virus fusion protein: implications for triggering of viral membrane fusion. J Biol Chem. 2009;284(3):1628-35. DOI: https://doi.org/10.1074/jbc.M807469200

Alizon S, Lion S, Murall CL, Abbate JL. Quantifying the epidemic spread of Ebola virus (EBOV) during the 2014 outbreak in West Africa. PLoS Curr. 2014;6:ecurrents.outbreaks.66bba3e7f6e1c0b4d9d7a6812811ccef.

Anthony SJ, Epstein JH, Murray KA, Navarrete-Macias I, Zambrana-Torrelio CM, Solovyov A, et al. A strategy to estimate unknown viral diversity in mammals. mBio. 2013;4(5):e00598-13. DOI: https://doi.org/10.1128/mBio.00598-13

Arankalle VA, Bandyopadhyay BT, Ramdasi AY, Jadi R, Patil DR, Rahman M, et al. Genomic characterization of Nipah virus, West Bengal, India. Emerg Infect Dis. 2011;17(5):907-9. DOI: https://doi.org/10.3201/eid1705.100968

Arunkumar G, Chandni R, Mourya DT, Singh SK, Sadanandan R, Sudan P, et al. Outbreak investigation of Nipah virus disease in Kerala, India, 2018. J Infect Dis. 2019;219(12):1867-78. DOI: https://doi.org/10.2139/ssrn.3216196

Bossart KN, Wang LF, Flora MN, Chua KB, Lam SK, Eaton BT, et al. Membrane fusion tropism and heterotypic functional activities of the Nipah virus and Hendra virus envelope glycoproteins. J Virol. 2002;76(22):11186-98. DOI: https://doi.org/10.1128/JVI.76.22.11186-11198.2002

Broder CC, Xu K, Nikolov DB, Zhu Z, Dimitrov DS, Middleton D, et al. A treatment for and vaccine against the deadly Hendra and Nipah viruses. Antiviral Res. 2013;100(1):8-13. DOI: https://doi.org/10.1016/j.antiviral.2013.06.012

Chua KB, Goh KJ, Wong KT, Kamarulzaman A, Tan PS, Ksiazek TG, et al. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet. 1999;354(9186):1257-9. DOI: https://doi.org/10.1016/S0140-6736(99)04299-3

Ciancanelli MJ, Volchkova VA, Shaw ML, Volchkov VE, Basler CF. Nipah virus sequesters RNA to evade innate immune recognition. PLoS Pathog. 2009;5(10):e1000641.

Daszak P, Olival KJ, Li H. A strategy to prevent future pandemics similar to COVID-19. Science. 2020;369(6507):379–381.

DeBuysscher BL, Scott D, Marzi A, Prescott J, Feldmann H. Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins. Vaccine. 2014;32(22):2637-44.

Duffy S, Shackelton LA, Holmes EC. Rates of evolutionary change in viruses: patterns and determinants. Nat Rev Genet. 2008;9(4):267-76. DOI: https://doi.org/10.1038/nrg2323

Eaton BT, Broder CC, Middleton D, Wang LF. Hendra and Nipah viruses: different and dangerous. Nat Rev Microbiol. 2006;4(1):23-35. DOI: https://doi.org/10.1038/nrmicro1323

Epstein JH, Field HE, Luby S, Pulliam JRC, Daszak P. Nipah virus: impact, origins, and causes of emergence. Curr Infect Dis Rep. 2006;8(1):59-65. DOI: https://doi.org/10.1007/s11908-006-0036-2

Escaffre O, Borisevich V, Rockx B. Pathogenesis of Nipah virus. Curr Opin Virol. 2013;3(3):276-83.

Guillaume V, Contamin H, Loth P, Georges-Courbot MC, Lefeuvre A, Marianneau P, et al. Nipah virus: vaccination and challenge in a hamster model. J Virol. 2004;78(2):834-40. DOI: https://doi.org/10.1128/JVI.78.2.834-840.2004

Gurley ES, Montgomery JM, Hossain MJ, Bell M, Azad AK, Islam MR, et al. Person-to-person transmission of Nipah virus in a Bangladeshi community. Emerg Infect Dis. 2007;13(7):1031-7. DOI: https://doi.org/10.3201/eid1307.061128

Hadfield J, Megill C, Bell SM, Huddleston J, Potter B, Callender C, et al. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics. 2018;34(23):4121-3. DOI: https://doi.org/10.1093/bioinformatics/bty407

Harcourt BH, Tamin A, Ksiazek TG, Rollin PE, Anderson LJ, Bellini WJ, et al. Molecular characterization of Nipah virus, a newly emergent paramyxovirus. Virology. 2000;271(2):334-49. DOI: https://doi.org/10.1006/viro.2000.0340

He S, Liu W, Jiang X, Tang Q, Zhang Y, Li Z, et al. Comparative evolutionary analysis of the Henipavirus genus. J Med Virol. 2021;93(5):2666-76.

Hegde ST, Salje H, Sazzad HM, Hossain MJ, Alam MU, Daszak P, et al. Investigating rare risk factors for Nipah virus in Bangladesh: 2001–2012. Ecohealth. 2016;13(4):720-8. DOI: https://doi.org/10.1007/s10393-016-1166-0

Khan SU, Gurley ES, Hossain MJ, Montgomery JM, Bell M, Azad AK, et al. A platform for rapid outbreak response in Bangladesh: implementation of a One Health approach. Transbound Emerg Dis. 2019;66(3):1040-51.

Kumar CP, Yadav PD, Shete AM, Radhakrishnan C, Sarkale P, Sahay RR, et al. Isolation of Nipah virus from humans during an outbreak of encephalitis in Kerala, India. J Infect Dis. 2019;219(12):1931-5.

Lo MK, Kondig JP, Feldmann F, Scott D, Marzi A, Haddock E, et al. Single-dose replication-defective VSV-based vaccine protects against lethal Nipah virus challenge. PLoS Negl Trop Dis. 2021;15(1):e0009051.

Lo MK, Rota PA. The emergence of Nipah virus, a highly pathogenic paramyxovirus. J Clin Virol. 2008;43(4):396-400. DOI: https://doi.org/10.1016/j.jcv.2008.08.007

Luby SP, Gurley ES, Hossain MJ. Transmission of human infection with Nipah virus. Clin Infect Dis. 2009;49(11):1743-8. DOI: https://doi.org/10.1086/647951

Luby SP, Hossain MJ, Gurley ES, Ahmed BN, Banu S, Khan SU, et al. Recurrent zoonotic transmission of Nipah virus into humans, Bangladesh, 2001–2007. Emerg Infect Dis. 2009;15(8):1229-35. DOI: https://doi.org/10.3201/eid1508.081237

Martin DP, Varsani A, Roumagnac P, Botha G, Maslamoney S, Schwab T, et al. RDP5: A computer program for analyzing recombination in, and removing signals of recombination from, nucleotide sequence datasets. Virus Evol. 2020;7(1):veaa087. DOI: https://doi.org/10.1093/ve/veaa087

Mathieu C, Horvat B. Henipavirus pathogenesis and antiviral approaches. Expert Rev Anti Infect Ther. 2015;13(3):343-54. DOI: https://doi.org/10.1586/14787210.2015.1001838

Menachery VD, Yount BL, Sims AC, Debbink K, Agnihothram SS, Gralinski LE, et al. SARS-like WIV1-CoV poised for human emergence. Proc Natl Acad Sci U S A. 2016;113(11):3048-53. DOI: https://doi.org/10.1073/pnas.1517719113

Negrete OA, Levroney EL, Aguilar HC, Bertolotti-Ciarlet A, Nazarian R, Tajyar S, et al. EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature. 2005;436(7049):401-5. DOI: https://doi.org/10.1038/nature03838

Patch JR, Crameri G, Wang LF, Eaton BT, Broder CC. Quantitative analysis of Nipah virus proteins released as virus-like particles reveals central role for the matrix protein. Virol J. 2007;4:1. DOI: https://doi.org/10.1186/1743-422X-4-1

Plowright RK, Becker DJ, Crowley DE, Washburne AD, Huang T, Nameer O, et al. Prioritizing surveillance of Nipah virus in India. PLoS Negl Trop Dis. 2019;13(6):e0007393. DOI: https://doi.org/10.1371/journal.pntd.0007393

Pomeroy LW, Bjørnstad ON, Holmes EC. The evolutionary and epidemiological dynamics of the paramyxoviridae. J Mol Evol. 2008;66(2):98-106. DOI: https://doi.org/10.1007/s00239-007-9040-x

Prescott J, DeBuysscher BL, Feldmann F, Gardner DJ, Haddock E, Martellaro C, et al. Single-dose live-attenuated Nipah virus vaccines confer complete protection. Vaccine. 2014;32(22):2637-44. DOI: https://doi.org/10.1016/j.vaccine.2014.02.087

Pulliam JRC, Epstein JH, Dushoff J, Rahman SA, Bunning M, Jamaluddin AA, et al. Agricultural intensification, priming for persistence, and the emergence of Nipah virus: a lethal bat-borne zoonosis. J R Soc Interface. 2012;9(66):89-101. DOI: https://doi.org/10.1098/rsif.2011.0223

Quick J, Loman NJ, Duraffour S, Simpson JT, Severi E, Cowley L, et al. Real-time, portable genome sequencing for Ebola surveillance. Nature. 2016;530(7589):228-32. DOI: https://doi.org/10.1038/nature16996

Rahman MA, Hossain MJ, Sultana S, Homaira N, Khan SU, Rahman M, et al. Date palm sap linked to Nipah virus outbreak, Bangladesh. Vector Borne Zoonotic Dis. 2012;12(2):65-72. DOI: https://doi.org/10.1089/vbz.2011.0656

Rahman SA, Hassan SS, Olival KJ, Mohamed M, Chang LY, Hassan L, et al. Characterization of Nipah virus from naturally infected Pteropus vampyrus bats. Emerg Infect Dis. 2010;16(12):1990-3. DOI: https://doi.org/10.3201/eid1612.091790

Rockx B, Bossart KN, Feldmann F, Geisbert JB, Hickey AC, Brining D, et al. A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment. J Virol. 2010;84(19):9831-9. DOI: https://doi.org/10.1128/JVI.01163-10

Shaw ML, Cardenas WB, Zamarin D, Palese P, Basler CF. Nuclear localization of the Nipah virus W protein allows for inhibition of both virus- and toll-like receptor 3-triggered signaling pathways. J Virol. 2005;79(10):6078-88. DOI: https://doi.org/10.1128/JVI.79.10.6078-6088.2005

Thibault PA, Watkinson RE, Moreira-Soto A, Drexler JF, Lee B. Zoonotic potential of emerging paramyxoviruses: knowns and unknowns. Adv Virus Res. 2017;98:1-55. DOI: https://doi.org/10.1016/bs.aivir.2016.12.001

Wang LF, Harcourt BH, Yu M, Tamin A, Rota PA, Bellini WJ, et al. Molecular biology of Hendra and Nipah viruses. Microbes Infect. 2001;3(4):279-87. DOI: https://doi.org/10.1016/S1286-4579(01)01381-8

Wang LF, Yu M, Hansson E, Pritchard LI, Shiell B, Michalski WP, et al. The exceptionally large genome of Hendra virus: support for creation of a new genus within the family Paramyxoviridae. J Virol. 2000;74(21):9972-9. DOI: https://doi.org/10.1128/JVI.74.21.9972-9979.2000

World Health Organization. Managing Nipah Virus: Outbreak Response Framework. Geneva: WHO; 2022. Available at: https://www.who.int/health-topics/nipah-virus-infection?. Accessed on 09 September 2025.

Yadav PD, Raut CG, Shete AM, Mishra AC, Towner JS, Nichol ST, et al. Detection of Nipah virus RNA in fruit bat (Pteropus giganteus) from India. Am J Trop Med Hyg. 2012;87(3):576-8. DOI: https://doi.org/10.4269/ajtmh.2012.11-0416

Yadav PD, Shete AM, Kumar GA, Sarkale P, Sahay RR, Radhakrishnan C, et al. Nipah virus sequences from humans and bats during the 2021 outbreak in Kerala, India. Emerg Infect Dis. 2019;25(5):1003-6. DOI: https://doi.org/10.3201/eid2505.181076

Downloads

Published

2026-02-27

How to Cite

Dangana, A., Omoare, A. A., Miri, N., Bwede, B. E., Dansura, M. L., Gagari, V. F., Uzoebo, N. L., Avong, J., Okoh, J., Jinadu, O., Demola, O., Babatunde, O., & Idris, O. (2026). Molecular diversity and evolutionary dynamics of Nipah virus: implications for surveillance and control . International Journal Of Community Medicine And Public Health, 13(3), 1535–1542. https://doi.org/10.18203/2394-6040.ijcmph20260719

Issue

Section

Review Articles